• PD-L1 testing by immunohistochemistry in Immuno-Oncology. 

      Vranic, Semir; Gatalica, Zoran ( Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina , 2022 , Article Review)
      Immunotherapy, based on immune checkpoint inhibitors targeting the Programmed cell death ligand 1 (PD-L1) and/or Programmed Death Receptor 1 (PD-1), has substantially improved the outcomes of patients with various cancers. ...